DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Teradata Corp
TDC
Collegium Pharmaceutical
COLL
Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 5.99%60.49B | 0.89%56.8B | 0.78%54.63B | -20.15%222.53B | -18.98%54.96B | -24.30%57.07B | -21.87%56.3B | -14.53%54.21B | 30.84%278.71B | 14.78%67.84B |
Operating revenue | 5.99%60.49B | 0.89%56.8B | 0.78%54.63B | -20.15%222.53B | -18.98%54.96B | -24.30%57.07B | -21.87%56.3B | -14.53%54.21B | 30.84%278.71B | 14.78%67.84B |
Cost of revenue | 9.42%40.06B | 2.14%36.82B | 7.85%37.73B | -5.33%144.79B | -4.03%37.15B | -7.85%36.61B | -6.58%36.04B | -2.60%34.99B | 8.50%152.94B | 7.54%38.71B |
Gross profit | -0.16%20.43B | -1.33%19.98B | -12.09%16.9B | -38.18%77.74B | -38.86%17.81B | -42.63%20.46B | -39.50%20.25B | -30.10%19.22B | 74.55%125.76B | 26.06%29.12B |
Operating expense | 21.23%6.4B | 30.33%6.17B | 9.65%5.36B | -7.64%20.45B | -0.57%5.55B | -6.73%5.28B | -15.86%4.73B | -7.32%4.89B | 6.98%22.15B | -0.39%5.58B |
Selling and administrative expenses | 2.92%2.54B | 2.10%2.48B | -21.83%2.39B | -22.76%10.7B | -18.80%2.75B | -29.34%2.46B | -30.43%2.43B | -12.32%3.05B | 9.43%13.86B | -0.38%3.39B |
-Selling and marketing expense | -2.56%716.51M | -5.40%677.65M | -28.03%683.99M | -22.90%3.23B | -13.59%823.24M | -30.67%735.3M | -21.72%716.31M | -24.25%950.31M | -10.46%4.18B | -23.15%952.7M |
-General and administrative expense | 5.25%1.82B | 5.23%1.8B | -19.04%1.7B | -22.70%7.48B | -20.83%1.93B | -28.76%1.73B | -33.52%1.71B | -5.60%2.1B | 21.06%9.67B | 12.66%2.44B |
Research and development costs | 23.54%4.02B | 16.14%3.85B | 23.16%3.41B | 2.55%13.28B | 15.79%3.94B | -1.49%3.26B | 3.37%3.32B | -8.78%2.77B | 0.14%12.95B | -0.22%3.41B |
Other operating expenses | 64.11%-158.19M | 83.80%-164.33M | 53.67%-429.67M | 24.27%-3.53B | 5.56%-1.15B | 61.08%-440.77M | 5.88%-1.01B | 25.00%-927.37M | 4.74%-4.66B | -0.12%-1.22B |
Operating profit | -7.60%14.03B | -10.99%13.81B | -19.51%11.54B | -44.71%57.29B | -47.94%12.26B | -49.40%15.18B | -44.27%15.52B | -35.52%14.33B | 101.79%103.62B | 34.53%23.54B |
Net non-operating interest income expense | -48.61%304.25M | -29.23%664.43M | -25.63%656.26M | 2,004.53%3.28B | 53.16%869.42M | 407.59%592.01M | 585.52%938.85M | 363.49%882.47M | 111.24%155.99M | 260.54%567.64M |
Non-operating interest income | -24.07%791.47M | -17.77%1.06B | -12.90%1.07B | 139.98%4.85B | 29.25%1.29B | 83.70%1.04B | 350.91%1.29B | 627.77%1.23B | 251.27%2.02B | 549.65%1B |
Non-operating interest expense | 9.82%466.92M | 14.18%358.34M | 22.88%395.09M | -17.45%1.47B | -0.77%413.18M | -0.86%425.17M | -29.99%313.84M | -34.62%321.53M | -4.43%1.79B | -16.23%416.38M |
Total other finance cost | -19.55%20.31M | 2.84%36.61M | -23.04%19.79M | 19.29%96.65M | -37.50%10.09M | 14.96%25.24M | 15.61%35.6M | 112.11%25.72M | -14.57%81.02M | 53.69%16.15M |
Other net income (expense) | -22.38%2.23B | -4.23%1.94B | -86.48%528.94M | 34.65%7.88B | -123.81%-939.06M | 29.17%2.87B | 197.78%2.03B | 122.81%3.91B | -31.45%5.85B | 272.93%3.94B |
Gain on sale of security | 418.19%530.51M | -59.88%193.71M | -42.39%269.02M | -54.61%601.63M | 66.80%-450.58M | 156.29%102.38M | 200.73%482.88M | -86.04%466.95M | -60.56%1.33B | -743.26%-1.36B |
Earnings from equity interest | -17.51%842.76M | 74.57%1.27B | -96.90%100.64M | 164.90%4.31B | -113.28%-688.1M | 211.54%1.02B | 135.83%726.06M | 274.77%3.25B | -68.69%1.63B | 739.57%5.18B |
Special income (charges) | -96.39%20.7M | -73.42%28.29M | -33.11%78.36M | 85.90%892.81M | 129.80%95.38M | 447.07%573.88M | -60.81%106.4M | 87.86%117.15M | 220.48%480.26M | -40.26%41.51M |
-Less:Restructuring and merger&acquisition | --0 | ---- | ---- | ---494M | --0 | ---494M | ---- | ---- | --0 | --0 |
-Write off | -91.88%121K | 21.53%-23.72M | -18.00%-45.53M | -4,893.17%-130.52M | -18,961.79%-63.19M | 129.23%1.49M | -1,226.91%-30.24M | -3,983.17%-38.59M | 144.49%2.72M | -88.25%335K |
-Gain on sale of business | --0 | --0 | --0 | ---- | ---- | --0 | --72K | --19.55M | ---- | ---- |
-Gain on sale of property,plant,equipment | -74.41%20.82M | -94.01%4.56M | -44.37%32.83M | -44.45%268.29M | 23.84%51.82M | -22.91%81.37M | -72.25%76.09M | -3.90%59.02M | 236.02%482.98M | -42.15%41.84M |
Other non- operating income (expenses) | -28.83%837.64M | -36.43%453.54M | -0.27%80.92M | -14.18%2.08B | 36.87%104.23M | -40.40%1.18B | 347.26%713.44M | -61.06%81.14M | 1,524.63%2.42B | 104.35%76.15M |
Income before tax | -11.18%16.56B | -11.17%16.42B | -33.50%12.72B | -37.56%68.45B | -56.56%12.19B | -42.35%18.65B | -27.73%18.49B | -19.11%19.13B | 87.41%109.63B | 88.70%28.05B |
Income tax | -20.88%2.12B | 2.17%2.65B | -16.50%2.29B | -57.00%8.31B | -95.55%295.94M | -46.38%2.68B | -36.66%2.59B | -23.40%2.74B | 144.08%19.33B | 95.92%6.65B |
Net income | -9.55%14.44B | -13.35%13.78B | -36.34%10.43B | -33.40%60.14B | -44.43%11.89B | -41.61%15.97B | -26.03%15.9B | -18.35%16.38B | 78.53%90.3B | 86.56%21.4B |
Net income continuous Operations | -9.55%14.44B | -13.35%13.78B | -36.34%10.43B | -33.40%60.14B | -44.43%11.89B | -41.61%15.97B | -26.03%15.9B | -18.35%16.38B | 78.53%90.3B | 86.56%21.4B |
Minority interest income | -490.91%-30.28M | -104.28%-10.95M | -113.17%-26.55M | -45.10%450.18M | -103.83%-1.99M | -101.48%-5.13M | 56.30%255.76M | -21.91%201.55M | 222.70%819.96M | -6.25%52.07M |
Net income attributable to the parent company | -9.39%14.47B | -11.86%13.79B | -35.39%10.46B | -33.29%59.69B | -44.29%11.89B | -40.84%15.97B | -26.66%15.64B | -18.30%16.18B | 74.60%89.48B | 87.02%21.35B |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -9.39%14.47B | -11.86%13.79B | -35.39%10.46B | -33.29%59.69B | -44.29%11.89B | -40.84%15.97B | -26.66%15.64B | -18.30%16.18B | 74.60%89.48B | 87.02%21.35B |
Basic earnings per share | -10.08%5.8 | -12.60%5.55 | -35.88%4.2 | -33.51%24.6 | -43.55%5.25 | -41.10%6.45 | -27.01%6.35 | -18.63%6.55 | 73.30%37 | 84.16%9.3 |
Diluted earnings per share | -9.45%5.75 | -12.00%5.5 | -35.16%4.15 | -32.68%24.1 | -42.13%5.15 | -40.65%6.35 | -26.47%6.25 | -18.99%6.4 | 70.88%35.8 | 81.63%8.9 |
Dividend per share | 0 | -17.33%14.8289 | 0 | 20.88%17.9366 | 0 | 0 | 20.88%17.9366 | 0 | 85.71%14.8386 | 0 |
Currency Unit | TWD | TWD | TWD | TWD | TWD | TWD | TWD | TWD | TWD | TWD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |